Roxadustat (FG-4592)

• Effect of Roxadustat on the Pharmacokinetics of Simvastatin, Rosuvastatin, and Atorvastatin in Healthy Subjects: Results From 3 Phase 1, Open‐Label, 1‐Sequence, Crossover Studies

  2022 Clinical Pharmacology in Drug Development article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

  13

  citations
• Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS)

  2021 Nephrology Dialysis Transplantation article Medicine Erythropoietin and Anemia Treatment Open access

  121

  citations
• Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan

  2020 Journal of the American Society of Nephrology article Medicine Erythropoietin and Anemia Treatment Open access

  208

  citations
• A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis

  2020 ˜The œNephron journals/Nephron journals article Medicine Erythropoietin and Anemia Treatment Open access

  63

  citations

4 results